Opendata, web and dolomites

Redwave

Redwave: the future of blood pressure measurement

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "Redwave" data sheet

The following table provides information about the project.

Coordinator
REDWAVE MEDICAL GMBH 

Organization address
address: HANS-KNOLL-STRASSE 6
city: JENA
postcode: 7745
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website https://redwave-medical.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REDWAVE MEDICAL GMBH DE (JENA) coordinator 50˙000.00

Map

 Project objective

Redwave is a breakthrough oscillometric solution which measures cBP, by combining a regular homecare BP monitor, with an algorithm, which uses the oscillating pressure curves of any BP monitor conducted in inflating and deflating process as input signals without any changes in the pumping protocol or in the hardware. The algorithm is based on an advanced development of Pulse Wave Analysis, a method already used in clinics and specialized practices which is matching the requirements e.g. in robustness and accuracy, of the non-controlled environment as it typically exists in home care measurements. For this reason, it enables the measurement of cBP in home care devices for the first time. It is the only solution which can be operated in a standard BP monitor without applying any changes to the BP monitor, because it detects the relevant information within the existing signal and processes this information. End users of the solution are people suffering from hypertension: they need a solution to help them manage their condition: in Europe, there are approximately 85M potential users of the solution. After receiving requests to use the algorithm in medical cohort trials, Redwave has a clear route to market entry by the end of 2018. The company is also aiming to increase its product portfolio with another algorithm for wrist BP devices by 2019, as it wants to continue developing R&D actions. From these efforts, new market opportunities will be assessed as the company's goal is to develop an entire family of algorithms around one core, which can be used in various devices and provide a variety of medical parameters to the users.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "REDWAVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "REDWAVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

MACCO (2019)

Bring social robots into reality with the first real world leading bartender (MACCO)

Read More  

ARON (2020)

Assay-Ready Organ Network

Read More